Hospital News and Research

RSS

Craneware reports 23% increase in revenues in the fiscal year-end results

Craneware, Inc. (AIM: CRW.L), a leader in sustainable financial improvement solutions for the U.S. healthcare market, is pleased to announce results for the year ended June 30, 2009.

9 Sep 2009

Wellmont partners with HealthSouth to open a new inpatient rehabilitation hospital in Bristol

Wellmont Health System and HealthSouth Corporation (NYSE: HLS) today announced that a joint venture entity formed by the two parties has been awarded a certificate of public need (COPN) to open a new inpatient rehabilitation hospital in Bristol, Va. The 25-bed hospital will enable more patients in Bristol and throughout Southwest Virginia to have access to comprehensive, high-quality rehabilitative services.

9 Sep 2009

New procedure used for breast cancer surgery

Breast cancer surgeons and radiation oncologists at St. Joseph Hospital in Orange performed a new procedure combining removal of a patient’s breast tumor with the power of electron beam radiation in the operating room.

8 Sep 2009

CHW urges Congress and Obama Administration to successfully conclude health care reform

Catholic Healthcare West (CHW) President/CEO Lloyd H. Dean unveiled a multi-faceted campaign today aimed at pushing health care reform in Washington to a successful conclusion. CHW’s “September for Reform” will bring the resources of one of America’s largest hospital systems to bear on the national health care reform debate with a focus on urging members of Congress and the Obama Administration to accomplish reform this fall.

8 Sep 2009

Mid-Atlantic region’s first laparoscopic gastric banding surgery performed at AEHN

Albert Einstein Healthcare Network (AEHN) announced today that its chief bariatric surgeon successfully performed the Mid-Atlantic region’s first laparoscopic gastric banding surgery, which is performed through a single incision in a patient’s umbilicus (or belly button), ultimately resulting in the potential for no visible scar.

8 Sep 2009

USA Today's 24-hour emergency room visit

A team of USA Today reporters spent a full, 24-hour day in the emergency room at University of Virginia Medical Center in late August. "The key elements of today's debate on health care converge in the ER, from the cutting-edge quality of the U.S. system to the millions of uninsured people who show up for care," according to the report. A key reform goal is covering an estimated 46 million uninsured Americans. But the task is expensive, and in many cases, born by ERs under the current system.

8 Sep 2009

MyMedicalRecords PHR offers medical reimbursement for H1N1 affected susbcribers

MMR Information Systems, Inc. (OTCBB: MMRF) (the "Company"), which through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. ("MMR") provides consumer-controlled Personal Health Records ("PHRs") (www.mymedicalrecords.com) and electronic safe deposit box storage solutions (www.myesafedepositbox.com), today announced that it has launched a new subscriber Program to reimburse up to $5,000 for remaining medical insurance deductibles, or out-of-pocket medical expenses up to $5,000, for a MyMedicalRecords PHR subscriber family member who has a confirmed case of the H1N1 (Swine Flu) virus.

8 Sep 2009

Valeant develops an acne drug with a low concentration of BPO combined with clindamycin

One of the most widely prescribed drugs for acne vulgaris is benzoyl peroxide (BPO). However, at concentrations of 5-10%, BPO has the potential for skin irritation and dryness leading to poor patient compliance. Increasingly, BPO is combined with clindamycin in a fixed combination where the efficacy effects of the two ingredients are synergistic.

8 Sep 2009

Haemonetics acquires SEBRA's blood collection and processing business

Haemonetics Corporation, a global blood management solutions company, and Engineering and Research Associates Inc. (known as "SEBRA(R)"), a leading provider of blood and medical manufacturing technologies, announced today that Haemonetics has acquired the assets of SEBRA's blood collection and processing business for $12.5 million cash. The acquisition is expected to close within the next several weeks.

8 Sep 2009

Pharos Innovations' RPM technology enables healthcare cost reduction

Pharos Innovations announced today that results of the Henry Ford Health System Patient-Centered Team Care program show a 36% reduction in expected all-cause hospital admissions for enrolled heart failure patients after six months of enrollment and a return of 2.3:1 vs. program costs.

8 Sep 2009

Legacy Hospital Partners renamed as LHP Hospital Group

Legacy Hospital Partners, Inc. is now LHP Hospital Group, Inc., (LHP). The organization has changed its name as it repositions for future growth.

8 Sep 2009

Pharma manufacturer's failure to disclose endangers Swine Flu vaccination program

As autumn approaches and millions of Americans consider taking an H1N1 Swine Flu vaccination, the integrity of all vaccine developers has been called into question by the financial relationship of a leading vaccine advocate and a pharmaceutical manufacturer. Dr. Paul Offit of Children's Hospital of Philadelphia (CHOP), who was interviewed for a Dateline NBC television special, failed to tell millions of viewers that while he was promoting MMR as safe he had also made tens of millions of dollars from selling another vaccine patent to Merck, which is the manufacturer of MMR.

8 Sep 2009

Third human clinical trial of LigoCyte's norovirus vaccine started

LigoCyte Pharmaceuticals, Inc. announced today that it has initiated its third human clinical trial of its norovirus vaccine. The Phase I/II study will assess safety and immunogenicity associated with LigoCyte's investigational, nasally-delivered, dry powder vaccine in healthy adults. The study will also assess potential protection against clinical symptoms of norovirus infection by including a live virus challenge of subjects that have received either the vaccine or placebo.

8 Sep 2009

Recruitment for the Phase IIa clinical trial to assess CNS 7056 sedative completed by PAION

The biopharmaceutical company PAION AG (ISIN DE000A0B65S3; Frankfurt Stock Exchange, Prime Standard: PA8) today announces the successful completion of the Recruitment for the Phase IIa clinical trial assessing the new short-acting intravenous anesthetic/sedative CNS 7056 in patients undergoing endoscopy of the upper gastrointestinal tract.

8 Sep 2009

Screening rates for colorectal cancer are lower in safety net health system, study reveals

Colorectal cancer screening rates are much lower among those in a safety net health system compared to the national average, and the number one predictor of screening is a combination of regular visits and insurance access.

8 Sep 2009

Renewal of CytoCare and i.v.STATION distribution agreements

Health Robotics today announced that after a successful first year of cooperation in Japan with Tosho Inc., the companies signed this week a contract renewal of the CytoCare and i.v.STATION exclusive distribution agreements, and an expansion of their strategic relationship to include future joint-development projects in their respective areas of Pharmacy Automation expertise.

7 Sep 2009

$geneX combined with Mesenchymal stem cells for treating fracture$

geneX combined with Mesenchymal stem cells for treating fracture

Professor James B. Richardson of the Robert Jones and Agnes Hunt Orthopaedic Hospital, Oswestry, UK has been carrying out pioneering work combining geneX with selected and culture expanded Mesenchymal stem cells to treat fracture non-unions.

7 Sep 2009

Early schizophrenia symptoms include unusually high CA1 subfield activity

In the first functional magnetic resonance imaging (fMRI) study of its kind, neurologists and psychiatrists at Columbia University have identified an area of the brain involved in the earliest stages of schizophrenia and related psychotic disorders.

7 Sep 2009

Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the blood-brain barrier

Earlier this year, researchers at the University of Washington reported that they had developed a toxin-nanoparticle combination that inhibits brain cancer invasion when added to tumor cells growing in culture.

7 Sep 2009

Rapid detection and profiling of cancer cells in fine-needle aspirates

Using a new type of paramagnetic nanoparticle and a nuclear magnetic resonance (NMR) system built into a microfluidic device, a team of investigators at the Massachusetts General Hospital and Harvard Medical School has created an assay system capable of detecting as few as two cancer cells in 1 microliter of biological fluid. In addition, the new assay requires little sample processing and produces results in less than 15 minutes.

7 Sep 2009

Hospital News and Research

Craneware reports 23% increase in revenues in the fiscal year-end results

Wellmont partners with HealthSouth to open a new inpatient rehabilitation hospital in Bristol

New procedure used for breast cancer surgery

CHW urges Congress and Obama Administration to successfully conclude health care reform

Mid-Atlantic region’s first laparoscopic gastric banding surgery performed at AEHN

USA Today's 24-hour emergency room visit

MyMedicalRecords PHR offers medical reimbursement for H1N1 affected susbcribers

Valeant develops an acne drug with a low concentration of BPO combined with clindamycin

Haemonetics acquires SEBRA's blood collection and processing business

Pharos Innovations' RPM technology enables healthcare cost reduction

Legacy Hospital Partners renamed as LHP Hospital Group

Pharma manufacturer's failure to disclose endangers Swine Flu vaccination program

Third human clinical trial of LigoCyte's norovirus vaccine started

Recruitment for the Phase IIa clinical trial to assess CNS 7056 sedative completed by PAION

Screening rates for colorectal cancer are lower in safety net health system, study reveals

Renewal of CytoCare and i.v.STATION distribution agreements

geneX combined with Mesenchymal stem cells for treating fracture

Early schizophrenia symptoms include unusually high CA1 subfield activity

Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the blood-brain barrier

Rapid detection and profiling of cancer cells in fine-needle aspirates

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News